Overview
Dynaglipt-M Tablets SR is a combination of Metformin (a biguanide) and Teneligliptin (a DPP-4 inhibitor), designed for the effective management of type 2 diabetes mellitus. This extended-release formulation helps control blood sugar levels throughout the day by improving insulin sensitivity and enhancing incretin activity. It is typically prescribed when diet, exercise, and monotherapy are insufficient to achieve adequate glycemic control.





